FSK · FS KKR Capital Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-11 | KROPP JAMES H |
Director |
Buy↑
|
Common Stock
(I)
|
1,100 |
| 2026-02-27 | KROPP JAMES H |
Director |
Buy↑
|
Common Stock
(I)
|
1,666 |
| 2026-02-27 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
|
5,000 |
| 2025-12-05 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
450 |
| 2025-11-11 | Forman Michael C. |
Director, See Remarks |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares received through stock distributions and shares received on account of reinvested distributions. |
Common Stock
(I)
|
10,000 |
| 2025-11-07 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
|
10,000 |
| 2025-09-03 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
330 |
| 2025-08-15 | Adams Barbara |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
3,750 |
| 2025-05-29 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
700 |
| 2025-01-01 | Forman Michael C. |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
Represents the vested portion of common stock granted by Franklin Square Holdings, L.P. ("FSH") to an officer of FS KKR Capital Corp. in connection with his service as an officer. The aggregate grant is 50,448 shares, of which 40,360 shares previously vested. The reporting person disclaims beneficial ownership of any shares held by FSH that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Includes shares received through stock distributions and shares received on account of reinvested distributions. |
Common Stock
(I)
|
10,088 |
| 2024-12-06 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
500 |
| 2024-12-05 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
|
5,000 |
| 2024-12-04 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |
| 2024-12-03 | Gerson Brian |
Co-President |
Buy↑
|
Common Stock
(I)
|
5,000 |
| 2024-11-25 | IMASOGIE OSAGIE O |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales were effectuated in multiple transactions at prices ranging from $21.97 to $22.04. The price reported in Column 4 is the weighted average price |
Common Stock
|
40,885 |
| 2024-08-15 | Forman Michael C. |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
FSH Seed Capital Vehicle I LLC is a wholly-owned special purpose financing subsidiary of Franklin Square Holdings, L.P. The reporting person disclaims beneficial ownership of any shares held by FSH Seed Capital Vehicle I LLC that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the report shares for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
180,704 |
| 2024-08-15 | Forman Michael C. |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
The reporting person disclaims beneficial ownership of any shares held by Franklin Square Holdings, L.P. that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
14,435 |
| 2024-08-08 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
Filing footnotes — Common Stock (Direct)
The purchases were effected in multiple transactions at prices ranging from $19.2050 to $19.2098, inclusive. The price reported in Column 4 is the weighted average price. |
Common Stock
|
5,000 |
| 2024-06-10 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
470 |
| 2024-05-15 | Adams Barbara |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
3,381 |
| 2024-05-14 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |
| 2024-02-29 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |
| 2024-02-28 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
Filing footnotes — Common Stock (Indirect)
The purchases were effected in multiple transactions at prices ranging from $18.75 to $18.77, inclusive. The price reported in Column 4 is the weighted average price. |
Common Stock
(I)
|
2,700 |
| 2024-02-28 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
Filing footnotes — Common Stock (Direct)
The purchases were effected in multiple transactions at prices ranging from $18.72 to $18.73, inclusive. The price reported in Column 4 is the weighted average price. |
Common Stock
|
7,300 |
| 2024-01-01 | Forman Michael C. |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
Represents the vested portion of common stock granted by Franklin Square Holdings, L.P. ("FSH") to an officer of FS KKR Capital Corp. in connection with his service as an officer. The aggregate grant is 50,448 shares, 30270 shares previously vested, and the remainder vests on January 1 of 2025. The reporting person disclaims beneficial ownership of any shares held by FSH that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
10,090 |
| 2023-12-08 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. Shares are indirectly owned through the reporting person's IRA. These shares were previously included in the reporting person's direct ownership total. |
Common Stock
(I)
|
500 |
| 2023-09-01 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |
| 2023-08-30 | Gerson Brian |
Co-President |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares are indirectly owned by the reporting person's spouse. |
Common Stock
(I)
|
1,000 |
| 2023-08-29 | Gerson Brian |
Co-President |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shared are indirectly owned through the reporting person's IRA. These shares were previously included in the reporting person's direct ownership total. |
Common Stock
(I)
|
2,000 |
| 2023-08-25 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
|
750 |
| 2023-08-11 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
|
5,000 |
| 2023-06-02 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
(I)
|
1,200 |
| 2023-05-11 | Adams Barbara |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The sales were effected in multiple transactions at prices ranging from $19.0550 to $19.0823, inclusive. The price reported in Column 4 is the weighted average price. Includes shares acquired under the FS KKR Capital Corp. dividend reinvestment plan. |
Common Stock
(I)
|
3,572 |
| 2023-03-15 | Hopkins Jerel A |
Director |
Buy↑
|
Common Stock
|
556 |
| 2023-03-10 | Goldstein Richard I |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The sales were effected in multiple transactions at prices ranging from $18.5669 to $18.9085. The price reported in Column 4 is the weighted average price. |
Common Stock
(I)
|
1,085 |
| 2023-03-09 | Sandler Elizabeth |
Director |
Buy↑
|
Common Stock
|
2,500 |
| 2023-03-07 | Gerson Brian |
Co-President |
Buy↑
|
Common Stock
|
3,000 |
| 2023-03-02 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
(I)
|
5,000 |
| 2023-01-01 | Forman Michael C. |
Director, See Remarks |
Sell↓
Filing footnotes — Common Stock (Indirect)
Represents the vested portion of common stock granted by Franklin Square Holdings, L.P. ("FSH") to an officer of FS KKR Capital Corp. in connection with his service as an officer. The aggregate grant is 50,448 shares, 20,180 shares previously vested, and the remainder vests in equal installments on January 1 of each of the next 2 years. The reporting person disclaims beneficial ownership of any shares held by FSH that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
10,090 |
| 2022-11-09 | Pietrzak Daniel |
Director, President and CIO |
Buy↑
|
Common Stock
|
6,000 |
| 2022-11-09 | Goldstein Richard I |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The sales were effected in multiple transactions at prices ranging from $18.8588 to $18.9700. The price reported in Column 4 is the weighted average price. |
Common Stock
(I)
|
1,175 |
| 2022-09-09 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The purchases were effected in multiple transactions at prices ranging from $21.375 to $21.3767, inclusive. The price reported in Column 4 is the weighted average price |
Common Stock
|
450 |
| 2022-08-22 | KROPP JAMES H |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |
| 2022-08-10 | Ford Brian R. |
Director |
Buy↑
|
Common Stock
|
500 |
| 2022-06-09 | Gerson Brian |
Co-President |
Buy↑
|
Common Stock
|
4,000 |
| 2022-06-09 | Hopkins Jerel A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The purchases were effected in multiple transactions at prices ranging from $21.204 to $21.205, inclusive. The price reported in Column 4 is the weighted average price. |
Common Stock
|
550 |
| 2022-05-27 | Gerson Brian |
Co-President |
Buy↑
|
Common Stock
|
2,000 |
| 2022-05-24 | Forman Michael C. |
Director, See Remarks |
Buy↑
Filing footnotes — Common Stock (Indirect)
The purchases were effected in multiple transactions at prices ranging from $20.40 to $20.50, inclusive. The price reported in Column 4 is the weighted average price. The reporting person disclaims beneficial ownership of any shares held by The 2011 Forman Investment Trust that exceed his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the report shares for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
5,488 |
| 2022-05-18 | Goldstein Richard I |
Director |
Buy↑
|
Common Stock
(I)
|
800 |
| 2022-05-17 | KROPP JAMES H |
Director |
Buy↑
|
Common Stock
(I)
|
1,000 |